People · Operator
Named in public records as an officer, director or promoter · active 2020–2021 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| InflammX Therapeutics, Inc. | — | Biotechnology | Series A | $15.4M | $156.4M | 2020 |
David Boyer at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Boyer on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James Blair | 1 | 8 |
| Brian Levy | 1 | 8 |
| David Pool | 1 | 4 |
| Jason Werner | 1 | 3 |
| Rajiv Shukla | 1 | 2 |
| Phil Rosenfeld | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.